True Nature, Mitesco, Biotech Stock Review

Is True Nature (TNTY) $0.04, Nearing a Breakout?

After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...

IDEALAB. First Mover, Last Survivor.

CLICK TO READ Founded by Bill Gross in 1996, Idealab has created more than 150 companies, which fueled...

Latest article

Internet Stock Review

New Preferred Stock IPOs, October 2019

Article ArchivePreferred Stock Investing Website Summary Thirteen new preferred stocks were introduced during October offering...
biogen, biotech stock review

“I Dare the FDA not to Approve Our Drug.”

"Woe, Woe, Woe Wait a Minute. We Meant That Biogen Respects and Appreciates the FDA Review Process.” All Hail the FDA! Biogen...
Mitesco, Biotech Stock Review

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.

This is a Welcome Step in the Right Direction. ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...